| Title : Cellular responses following ex vivo lung exposure to the nerve agent VX - Potential for additional treatment targets? - Wigenstam_2024_Chem.Biol.Interact_403_111225 |
| Author(s) : Wigenstam E , Bucht A , Thors L |
| Ref : Chemico-Biological Interactions , 403 :111225 , 2024 |
| Abstract : |
| PubMedSearch : Wigenstam_2024_Chem.Biol.Interact_403_111225 |
| PubMedID: 39233266 |
| Title : Supplemental treatment to atropine improves the efficacy to reverse nerve agent induced bronchoconstriction - Wigenstam_2022_Chem.Biol.Interact__110061 |
| Author(s) : Wigenstam E , Artursson E , Bucht A , Thors L |
| Ref : Chemico-Biological Interactions , :110061 , 2022 |
| Abstract : |
| PubMedSearch : Wigenstam_2022_Chem.Biol.Interact__110061 |
| PubMedID: 35872047 |
| Title : Efficacy of atropine and scopolamine on airway contractions following exposure to the nerve agent VX - Wigenstam_2021_Toxicol.Appl.Pharmacol__115512 |
| Author(s) : Wigenstam E , Forsberg E , Bucht A , Thors L |
| Ref : Toxicol Appl Pharmacol , :115512 , 2021 |
| Abstract : |
| PubMedSearch : Wigenstam_2021_Toxicol.Appl.Pharmacol__115512 |
| PubMedID: 33785355 |
| Title : Efficient agent degradation within skin is important for decontamination of percutaneously exposed VX - Thors_2021_Cutan.Ocul.Toxicol__1 |
| Author(s) : Thors L , Wigenstam E , Qvarnstrom J , Bucht A |
| Ref : Cutan Ocul Toxicol , :1 , 2021 |
| Abstract : |
| PubMedSearch : Thors_2021_Cutan.Ocul.Toxicol__1 |
| PubMedID: 33759679 |